Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Why Rheumatologist–Pulmonologist Collaboration Is Essential

Vanessa Caceres  |  Issue: June 2015  |  June 15, 2015

Dr. Kaplan would like pulmonologists to keep systemic conditions in mind as they evaluate patients. “When they see problems such as interstitial lung disease or other inflammatory conditions of the lung, they may be part of the larger picture of an underlying connective tissue disease. They may want to send the patient to a rheumatologist for an evaluation,” he says.

Conversely, agents prescribed typically by rheumatologists can assist with blocking lung disease at times, Dr. Efthimiou says. “Often, systemic immunotherapy, expertly administered by experienced rheumatologists, may halt or reverse the lung pathologic process and lead to better outcomes in affected patients,” he says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Vanessa Caceres is a medical writer in Bradenton, Fla.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Clinical Crossover Between Rheumatologists & Pulmonologists

  • Eosinophilic granulomatosis with polyangiitis
  • Diffuse alveolar hemorrhage
  • Granulomatosis with polyangiitis
  • Interstitial lung disease
  • Microscopic polyangiitis
  • Sarcoidosis
  • Sjögren’s syndrome with lung disease
  • Scleroderma with pulmonary arterial hypertension
  • Systemic lupus erythematosus
  • Systemic sclerosis
  • Vasculitis

Page: 1 2 3 | Single Page
Share: 

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:collaborationlung diseasepatient carepulmonologistrheumatologist

Related Articles

    Lung Complications Closely Entwined with Rheumatologic Diseases

    September 8, 2016

    SAN FRANCISCO—Lung involvement is a frequent and often life-threatening manifestation of the connective tissue diseases (CTDs) that are commonly encountered by rheumatologists. A variety of rheumatic diseases can affect the lungs, including systemic sclerosis, rheumatoid arthritis, vasculitis, lupus, polymyositis/dermatomyositis (PM/DM) and Sjögren’s syndrome. A panel presentation on lung disease associated with rheumatic diseases at the…

    New Africa / shutterstock.com

    A Rheumatologist & Pulmonologist Discuss RA-ILD

    November 14, 2021

    Introduction The understanding and treatment of rheuma­toid arthritis (RA) has evolved dramatically in the past 20 years. As gains have been made in treating joint disease in RA, our understanding of the impact of extra-articular manifestations of RA, such as cardiac and lung disease—specifically interstitial lung disease (ILD)—has gradually increased. While rheumatologists increasingly appreciate the…

    Labored Breathing

    January 1, 2007

    Strategies to diagnose and manage dyspnea in the scleroderma patient

    What Our Colleagues Should Know: Integrated Care for the Lungs

    February 17, 2017

    Multi-system diseases have unique challenges. And Dr. Aryeh Fischer says that when treating patients with interstitial lung disease, pulmonologists and rheumatologists must better understand “how we [both] approach our shared diseases.”

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences